New publication: Environmental risk or benefit? Comprehensive risk assessment of groundwater treated with nano Fe0-based Carbo-Iron®

For the treatment of groundwater contaminated with chlorinated hydrocarbons, nano-scaled zero-valent iron (nano Fe0) represents an efficient alternative to other treatments as e.g. pump & treat. Upon selection of a suitable treatment method for a given groundwater a risk-cost-benefit analysis is performed. This analysis does only rarely consider the potential risk of the remediation method […]

ECT at the SETAC Europe 29th Annual Meeting

ECT at the SETAC Europe 29th Annual Meeting

ECT is contributing to the SETAC Europe 29th Annual Meeting ‘One environment. One health. Sustainable societies’ that takes place in Helsinki, Finland, from May 26th to 30th, 2019. It addition to the presentations and activities indicated below, ECT presents its work at booth number 29.

Symposium on soil biodiversity and how to protect soil ecosystems

The SETAC Europe 14th Special Science Symposium ‘Soil biodiversity: what do we know and how to protect it from adverse effects of plant protection products and other chemicals’ will be held on 19-20 November 2019 in Brussels. Within the framework of current regulations on chemicals in soil, the protection of the structure and functioning of […]

New publication: Compartment‐specific screening tools for persistence – potential role and application in the regulatory context

The persistence assessment under REACH relies on compartment‐specific degradation half‐lives derived from laboratory simulation studies with surface water, aquatic sediment or soil. Although these data are given priority, they are not available for most of the compounds. Therefore, according to the integrated assessment and testing strategy for persistence assessment, results from ready biodegradability tests are […]

Conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’

The two-day international conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’ will mark the end of the IMI-funded project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE). The conference will take place on 24-25 June 2019 at the University of York (UK). It will provide an overview on […]

Presentation of the iPiE project at the SETAC Europe meeting

The project Intelligence-led assessment of pharmaceuticals in the environment (iPiE) will be presented at the SETAC Europe Annual Meeting in Helsinki, at a symposium organised by the SETAC Europe Pharmaceutical Interest Group. The symposium will take place on Sunday, 26 May 2019 (13:00 – 17:30). Its aim is to present the iPiE project in detail […]

New publication: Impact of an immunosuppressive human pharmaceutical on the interaction of a bacterial parasite and its invertebrate host

The interaction of pollutants and pathogens may result in altered (often enhanced) effects of the chemical, the biotic stressor or both. While standardised detection methods for immunotoxic effects of chemicals exist with regard to human health, such test systems are lacking for invertebrate species and no guidance is available on how immunotoxic effects of a […]

Interview with Anja Coors in the current iPiE Newsletter

ECT is involved in the project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE).  The iPiE project contributes to developing frameworks for intelligence-based environmental testing of pharmaceuticals and for prioritising legacy pharmaceuticals for targeted environmental risk assessment and environmental (bio-) monitoring. The current iPiE newsletter (Newsletter No 6) features an interview with Anja Coors, who […]